This Article Full Text Full Text (PDF) All Versions of this Article: 110/20/3270    most recent 01.CIR.0000147610.41984.E8v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nordmeyer, J. Articles by Regitz-Zagrosek, V. Search for Related Content PubMed PubMed Citation Articles by Nordmeyer, J. Articles by Regitz-Zagrosek, V. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Compound via MeSH Substance via MeSH Related Collections Other myocardial biology Hypertrophy Valvular heart disease

(Circulation. 2004;110:3270-3275.)
© 2004 American Heart Association, Inc.

Valvular Heart Disease

Upregulation of Myocardial Estrogen Receptors in Human Aortic Stenosis

Johannes Nordmeyer, AS^*; Sarah Eder, AS^*; Shokoufeh Mahmoodzadeh, PhD; Peter Martus, PhD; Jens Fielitz, MD; Jan Bass, AS; Nicole Bethke, AS; Heinz R. Zurbrügg, MD; Reinhard Pregla, MD; Roland Hetzer, MD; Vera Regitz-Zagrosek, MD

From Cardiovascular Disease in Women, Charite and Deutsches Herzzentrum Berlin (J.N., S.E., S.M., J.F., J.B., N.B., V.R.-Z); Charite and Deutsches Herzzentrum Berlin (R.H.); Klinik für Herz-, Gefäss- und Thoraxchirurgie, Deutsches Herzzentrum Berlin (H.R.Z., R.P.); and Institute for Medical Informatics, Biometry and Epidemiology, Charite (P.M.), Berlin, Germany.

Correspondence to Vera Regitz-Zagrosek, MD, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. E-mail zagrosek{at}dhzb.de

Received May 19, 2004; revision received August 21, 2004; accepted August 25, 2004.

Background— Estrogen receptor (ER)–mediated effects have been associated with the modulation of myocardial hypertrophy in animal models and in humans, but ER expression in the human heart and its relation to hypertrophy-mediated gene expression have not yet been analyzed. We therefore investigated sex- and disease-dependent alterations of myocardial ER expression in human aortic stenosis together with the expression of hypertrophy-related genes.

Methods and Results— ER- and -ß, calcineurin A-ß, and brain natriuretic peptide (BNP) mRNA were quantified by real-time polymerase chain reaction in left ventricular biopsies from patients with aortic valve stenosis (n=14) and control hearts with normal systolic function (n=17). ER protein was quantified by immunoblotting and visualized by immunofluorescence confocal microscopy. ER- mRNA and protein were increased 2.6-fold (P=0.003) and 1.7-fold (P=0.026), respectively, in patients with aortic valve stenosis. Left ventricular ER-ß mRNA was increased 2.6-fold in patients with aortic valve stenosis (P<0.0001). ER- and -ß were found in the cytoplasm and nuclei of human hearts. A strong inverse correlation exists between ER-ß and calcineurin A-ß mRNA in patients with aortic valve stenosis (r=–0.83, P=0.002) but not between ER- or -ß and BNP mRNA.

Conclusions— ER- and -ß in the human heart are upregulated by myocardial pressure load.

Key Words: receptors, estrogen • stenosis, aortic valve • hypertrophy

This article has been cited by other articles:

				S. Domingues-Montanari, I. Subirana, M. Tomas, J. Marrugat, and M. Senti Association between ESR2 Genetic Variants and Risk of Myocardial Infarction Clin. Chem., July 1, 2008; 54(7): 1183 - 1189. [Abstract] [Full Text] [PDF]

				V. Jazbutyte, P. A. Arias-Loza, K. Hu, J. Widder, V. Govindaraj, C. von Poser-Klein, J. Bauersachs, K.-H. Fritzemeier, C. Hegele-Hartung, L. Neyses, et al. Ligand-dependent activation of ER{beta} lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats Cardiovasc Res, March 1, 2008; 77(4): 774 - 781. [Abstract] [Full Text] [PDF]

				D. Liu, A. Deschamps, K. S. Korach, and E. Murphy Estrogen-Enhanced Gene Expression of Lipoprotein Lipase in Heart Is Antagonized by Progesterone Endocrinology, February 1, 2008; 149(2): 711 - 716. [Abstract] [Full Text] [PDF]

				J. P. Konhilas and L. A. Leinwand The Effects of Biological Sex and Diet on the Development of Heart Failure Circulation, December 4, 2007; 116(23): 2747 - 2759. [Full Text] [PDF]

				C. Bolego, E. Vegeto, C. Pinna, A. Maggi, and A. Cignarella Selective Agonists of Estrogen Receptor Isoforms: New Perspectives for Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2192 - 2199. [Abstract] [Full Text] [PDF]

				V. Jazbutyte, K. Hu, P. Kruchten, E. Bey, S. K.G. Maier, K.-H. Fritzemeier, K. Prelle, C. Hegele-Hartung, R. W. Hartmann, L. Neyses, et al. Aging Reduces the Efficacy of Estrogen Substitution to Attenuate Cardiac Hypertrophy in Female Spontaneously Hypertensive Rats Hypertension, October 1, 2006; 48(4): 579 - 586. [Abstract] [Full Text] [PDF]

				S. Mahmoodzadeh, S. Eder, J. Nordmeyer, E. Ehler, O. Huber, P. Martus, J. Weiske, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek Estrogen receptor alpha up-regulation and redistribution in human heart failure FASEB J, May 1, 2006; 20(7): 926 - 934. [Abstract] [Full Text] [PDF]

				G. Schonfelder The biological impact of estrogens on gender differences in congestive heart failure Cardiovasc Res, September 1, 2005; 67(4): 573 - 574. [Full Text] [PDF]